CGON
CGON
NASDAQ · Biotechnology

Cg Oncology Inc

$75.10
+0.25 (+0.33%)
As of Aug 8, 9:55 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -52.1% upside
Low Target $23.54
Average Target $35.94
High Target $41.91
Current Price $75.10
Current
$75.10
Target
$35.94
$23.54 $35.94 avg $41.91
Scenario Analysis
Bear Case
$23.54
-68.7%
Low target
Base Case
$35.94
-52.1%
Avg target
Bull Case
$41.91
+-44.2%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$77.00
-2.5% from high
52-Week Low
$23.65
+217.5% from low
50-Day SMA
$47.74
+57.3% vs SMA
200-Day SMA
$36.07
+108.2% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$35.94
-53.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%